Inhibition of P-glycoprotein-mediated efflux by thiolated cyclodextrins.

[1]  Rawiwan Maniratanachote,et al.  Quaternization of high molecular weight chitosan for increasing intestinal drug absorption using Caco-2 cells as an in vitro intestinal model , 2023, Scientific reports.

[2]  A. Bernkop‐Schnürch,et al.  Thiolated α-cyclodextrin: The likely smallest drug carrier providing enhanced cellular uptake and endosomal escape. , 2023, Carbohydrate polymers.

[3]  A. Silva,et al.  Natural Products as a Tool to Modulate the Activity and Expression of Multidrug Resistance Proteins of Intestinal Barrier , 2023, Journal of xenobiotics.

[4]  A. Bernkop‐Schnürch,et al.  Thiolated cyclodextrins: A comparative study of their mucoadhesive properties. , 2023, International journal of pharmaceutics.

[5]  G. Yahya,et al.  Pharmaceutical polymers and P-glycoprotein: Current Trends and Possible Outcomes in Drug Delivery , 2023, Materials Today Communications.

[6]  A. Bernkop‐Schnürch,et al.  Per-thiolated cyclodextrins: Nanosized drug carriers providing a prolonged gastrointestinal residence time. , 2022, Carbohydrate polymers.

[7]  S. Thayumanavan,et al.  Thiol-Disulfide Exchange as a Route for Endosomal Escape of Polymeric Nanoparticles. , 2022, Angewandte Chemie.

[8]  M. Kao,et al.  Novel application of rhein and its prodrug diacerein for reversing cancer-related multidrug resistance through the dual inhibition of P-glycoprotein efflux and STAT3-mediated P-glycoprotein expression. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  Xiaoqing Miao,et al.  Strategies and Mechanism in Reversing Intestinal Drug Efflux in Oral Drug Delivery , 2022, Pharmaceutics.

[10]  A. Piras,et al.  Thiolated Hydroxypropyl-β-cyclodextrin: A Potential Multifunctional Excipient for Ocular Drug Delivery , 2022, International journal of molecular sciences.

[11]  Mei Wang,et al.  Comparison of the permeability between conjugated estrogens and atenolol in rat in situ single-pass intestinal perfusions model and in Caco-2 cell monolayers , 2022, Journal of Drug Delivery Science and Technology.

[12]  K. Giacomini,et al.  Interaction of Commonly Used Oral Molecular Excipients with P-glycoprotein , 2021, The AAPS Journal.

[13]  C. Hrycyna,et al.  The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors , 2021, Cancer drug resistance.

[14]  A. Bernkop‐Schnürch,et al.  Thiolated pectins: In vitro and ex vivo evaluation of three generations of thiomers. , 2021, Acta biomaterialia.

[15]  A. Bernkop‐Schnürch,et al.  Thiolated cyclodextrins: Mucoadhesive and permeation enhancing excipients for ocular drug delivery. , 2021, International journal of pharmaceutics.

[16]  A. Bernkop‐Schnürch,et al.  Thiolated cyclodextrins: New perspectives for old excipients , 2020, Coordination Chemistry Reviews.

[17]  A. Bernkop‐Schnürch,et al.  Per-6-Thiolated Cyclodextrins: A Novel Type of Permeation Enhancing Excipients for BCS Class IV Drugs , 2020, ACS applied materials & interfaces.

[18]  Liping Wang,et al.  Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin. , 2019, Colloids and surfaces. B, Biointerfaces.

[19]  B. Vaidya,et al.  Nintedanib-cyclodextrin complex to improve bio-activity and intestinal permeability. , 2019, Carbohydrate polymers.

[20]  L. Szente,et al.  Complex Formation of Resorufin and Resazurin with Β-Cyclodextrins: Can Cyclodextrins Interfere with a Resazurin Cell Viability Assay? , 2018, Molecules.

[21]  Qiang Zhang,et al.  The P-glycoprotein inhibitory effect and related mechanisms of thiolated chitosan and its S-protected derivative , 2015 .

[22]  R. Sikes,et al.  Cell-based assays using calcein acetoxymethyl ester show variation in fluorescence with treatment conditions. , 2015, Journal of biological methods.

[23]  A. Bernkop‐Schnürch,et al.  Thiomers: Influence of molecular mass and thiol group content of poly(acrylic acid) on efflux pump inhibition. , 2015, International journal of pharmaceutics.

[24]  C. Huck,et al.  Synthesis and In Vitro Evaluation of Thiolated Carrageenan. , 2015, Journal of pharmaceutical sciences.

[25]  H. Valizadeh,et al.  Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions , 2014, Expert opinion on drug metabolism & toxicology.

[26]  N. Cioffi,et al.  Mucoadhesive properties and interaction with P-glycoprotein (P-gp) of thiolated-chitosans and -glycol chitosans and corresponding parent polymers: a comparative study. , 2014, Biomacromolecules.

[27]  A. Yu,et al.  ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development. , 2014, Current pharmaceutical design.

[28]  Ye Zhang,et al.  Effects of β-cyclodextrin on the intestinal absorption of berberine hydrochloride, a P-glycoprotein substrate. , 2013, International journal of biological macromolecules.

[29]  P. Nagy.  Kinetics and mechanisms of thiol-disulfide exchange covering direct substitution and thiol oxidation-mediated pathways. , 2013, Antioxidants & redox signaling.

[30]  Md. Lutful Amin.  P-glycoprotein Inhibition for Optimal Drug Delivery , 2013, Drug target insights.

[31]  A. Bernkop‐Schnürch,et al.  S-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory properties. , 2012, Molecular pharmaceutics.

[32]  J. Iqbal,et al.  Thiolated chitosans: influence of various sulfhydryl ligands on permeation-enhancing and P-gp inhibitory properties , 2011, Drug development and industrial pharmacy.

[33]  J. Iqbal,et al.  Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[34]  H. Takeuchi,et al.  Modified chitosans for oral drug delivery. , 2009, Journal of pharmaceutical sciences.

[35]  Gautam Mishra,et al.  Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[36]  A. Bernkop‐Schnürch,et al.  In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein. , 2006, Biomaterials.

[37]  A. Bernkop‐Schnürch,et al.  In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan. , 2006, Biomaterials.

[38]  Martin Werle,et al.  Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[39]  J. Moore,et al.  Use of Verapamil as a Potential P-Glycoprotein Inhibitor in a Patient with Refractory Epilepsy , 2004, The Annals of pharmacotherapy.

[40]  W. Dalton,et al.  Reversal of drug‐resistance in multiple myeloma with verapamil , 1988, British journal of haematology.

[41]  Liefeng Zhang,et al.  A cell-penetrating peptide conjugated carboxymethyl-β-cyclodextrin to improve intestinal absorption of insulin. , 2018, International journal of biological macromolecules.

[42]  J. Iqbal,et al.  Development and in vivo evaluation of an oral drug delivery system for paclitaxel. , 2011, Biomaterials.